September 9, 2025

Dr. Suzanne Cole on using real-world data to improve the generalizability of clinical trial results (highlights PrE1702 and EA5182)

September 8, 2025

EA5181 trial finds no survival benefit for concurrent and consolidative durvalumab vs consolidation alone in unresectable non-small cell lung cancer

August 14, 2025

A new biomarker, KIM-1, may predict outcomes and response in kidney cancer (mentions E2805/ASSURE)

August 6, 2025

Treatment headway gives much-needed hope in small-cell lung cancer (discusses EA5161 and other trials)

August 5, 2025

Trial Spotlight: Dr. Ken Cardona gives an update on the STRASS 2 sarcoma trial (EA7211)

August 3, 2025

Critical role of ongoing EA9181 trial for Ph+ ALL highlighted in Blood Cancers Today

July 18, 2025

Podcast: ASCO Guidelines update on therapy for stage 4 non-small cell lung cancer with driver alterations (mentions EA5182)

July 17, 2025

New Publication: NCI-MATCH study shows positive results for ipatasertib in patients with AKT-mutated solid tumors

May 4, 2025

EA5161 among a meta-analysis of 12 small cell lung cancer trials published in Translational Lung Cancer Research

ECOG-ACRIN Cancer Research Group